Recently, a truncated variant of transthyretin together with apolipoprotein A1 and a connective tissue activating protein III were described as an efficient panel of new biomarkers for detecting early stage epithelial ovarian cancer in women [23]. This evidence concerns the gene TTR and ovarian carcinoma.